EPHA2 and neoplasm: Therefore, in the present study, we aimed to directly evaluate the oncogenic role of EphA2 using shRNA-mediated knockdown in a syngeneic RCC model, thereby preserving tumor–immune interactions and enabling longitudinal in vivo monitoring.